Cardinal Health (NYSE:CAH) Releases Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Cardinal Health (NYSE:CAH) issued its earnings results on Wednesday. The company reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.10, RTT News reports. The business had revenue of $59.87 billion for the quarter, compared to analyst estimates of $58.74 billion. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.55 EPS. Cardinal Health updated its FY 2025 guidance to 7.550-7.700 EPS and its FY25 guidance to $7.55-7.70 EPS.

Cardinal Health Trading Up 1.4 %

CAH stock traded up $1.54 during trading hours on Thursday, hitting $107.90. 3,140,944 shares of the stock traded hands, compared to its average volume of 2,152,978. The stock has a 50-day simple moving average of $98.97 and a 200 day simple moving average of $103.18. Cardinal Health has a one year low of $85.11 and a one year high of $116.04. The company has a market cap of $26.28 billion, a P/E ratio of 48.00, a P/E/G ratio of 1.14 and a beta of 0.61.

Analyst Ratings Changes

CAH has been the subject of a number of recent research reports. Evercore ISI boosted their price objective on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research report on Thursday. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 8th. Citigroup reduced their price objective on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. Argus dropped their target price on Cardinal Health from $120.00 to $115.00 and set a “buy” rating on the stock in a research report on Wednesday, May 15th. Finally, Wells Fargo & Company boosted their price target on shares of Cardinal Health from $95.00 to $101.00 and gave the company an “underweight” rating in a report on Thursday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $113.25.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.